REQUEST A DEMO
Total
USD $0.00
Search more companies

Novartis Biociencias S.A. (Brazil)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Novartis Biociencias S.A. Profile Updated: July 22, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English & Portuguese Download a sample report

Novartis offers its products and services in the following divisions: Novartis Pharma, focused on the production andmarketing of prescription drugs; Sandoz, which produces and markets generic drugs, Novartis Consumer Health, which operates in the area of contact lenses, cleaning solutions, animal health and prescription free drugs; and the newly formed Division of Vaccines and Diagnostics.

Headquarters
Av. Professor Vicente Rao, 90, Blooklim Paulista.
Sao Paulo; Sao Paulo; Postal Code: 04706-900

Contact Details: Purchase the Novartis Biociencias S.A. report to view the information.

Website: https://www.novartis.com.br/

Basic Information
Registered Capital:
Purchase the Novartis Biociencias S.A. report to view the information.
Financial Auditors:
Purchase the Novartis Biociencias S.A. report to view the information.
Incorporation Date:
July 27, 1966
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Novartis Consumer Health Ltda
99.99%
Novartis Consumer Health Ltda.
Company Performance
Financial values in the chart are available after Novartis Biociencias S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BRL. Absolute financial data is included in the purchased report.
Net sales revenue
10.61%
Total operating revenue
10.61%
Operating profit (EBIT)
N/A
EBITDA
-91.95%
Net Profit (Loss) for the Period
N/A
Total assets
-1.26%
Total equity
-44.15%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
125%
Quick Ratio
-0.07%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?